E. Hardin

发表

Approaches in the Chemoprevention of Breast Cancer

H. Nair, K. V. Dileep, M. Kelly, 2013 .

Adjuvant Using TLR 7 Agonist Imiquimod as Vaccine Patients with Full-Length NY-ESO-1 Protein Immunization of Malignant Melanoma

Linda, S. Adams, L. Chiriboga, 2008 .

Immunization of Malignant Melanoma Patients with Full-Length NY-ESO-1 Protein Using TLR7 Agonist Imiquimod as Vaccine Adjuvant1

S. Adams, L. Chiriboga, A. Pavlick, 2008, The Journal of Immunology.

A phase II trial of BAY 43-9006 in metastatic melanoma with molecularly characterized B-Raf status.

D. Polsky, I. Osman, A. Pavlick, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.